Pediatric type 1 diabetes clinic nursing requires explaining three biological realities that all look, from the family’s perspective, like the opposite of what they are. A child in the honeymoon phase whose glucose runs between 80 and 140 on minimal insulin looks recovered — the disease appears to be resolving. A child with T1D and positive celiac antibodies who has never had diarrhea, abdominal pain, or weight loss looks unaffected by celiac disease — the gastrointestinal damage appears absent. A child with T1D who is vomiting during a viral illness and has eaten nothing in twelve hours looks like a child who does not need insulin — there is no food to cover. In each case, the family’s model is built from direct observation and is reasonable within the framework of general medical knowledge. In each case, acting on that model produces clinical consequences ranging from progressive beta-cell loss to glycemic chaos to diabetic ketoacidosis.
Spanish for pediatric type 1 diabetes clinic nurses begins with recognizing that these three communication gaps are not failures of attention or engagement on the family’s part. They are failures of framework — cases where the observable facts point in exactly the wrong direction, and where the correct clinical interpretation requires knowledge of biological processes (the continued autoimmune attack during the honeymoon, the HLA-linked co-occurrence of autoimmune diseases, the counter-regulatory hormone physiology of sick-day DKA) that are invisible to the family and absent from general medical knowledge. The bilingual nurse who can make these invisible processes visible in Spanish gives families the framework they need to act correctly on information they can observe.
The three conversations in this post take place in Houston, San Antonio, and Dallas, in the outpatient pediatric endocrinology clinics of children’s hospitals and large pediatric diabetes programs serving primarily Spanish-speaking families. Each involves a family that is engaged, has maintained clinic appointments reliably, and arrives at a recommendation that appears to exceed — or contradict — what their direct observation of their child’s current state warrants.
Scenario 1: Miguel Rojas-Torres — Houston, Texas
Pediatric T1D nurse Ana Cisneros-Morales and the parents who cannot understand why insulin must continue when the honeymoon phase makes it seem unnecessary
Miguel is nine years old. He was born in Houston to Pedro Rojas-García, forty-three, an electrician, and Carmen Torres-Cruz, thirty-nine, a home health aide for an elderly client in their neighborhood. Three months ago, Miguel was brought to the emergency department with lethargy, vomiting, and three days of increased thirst and urination. His blood glucose was 480 mg/dL. His bicarbonate was 8 mEq/L. His pH was 7.18. He was admitted with moderate diabetic ketoacidosis, given IV insulin and fluids, and diagnosed with type 1 diabetes mellitus. He spent three days in the hospital and was discharged on basal-bolus insulin: glargine 10 units at bedtime and a rapid-acting analog at meals calculated at 1 unit per 15 grams of carbohydrates.
Three months later, Miguel is at his first endocrinology clinic follow-up since the one-month post-discharge visit. Pedro and Carmen have been meticulous with glucose monitoring, carbohydrate counting, and injection timing. Today, the numbers on Miguel’s continuous glucose monitor tell a story that confuses them both. His glucose is running between 80 and 140 most of the day. His A1c is 5.9%. His glargine dose has been titrated down to 4 units. His mealtime insulin is often not needed at all — many meals produce no significant glucose rise. His total daily insulin dose has dropped from 0.8 units per kilogram per day at discharge to 0.2 units per kilogram per day now. His C-peptide, drawn before today’s visit, is detectable at 0.4 nmol/L.
Pedro opens the conversation: “Enfermera, queremos entender lo que está pasando. Tres meses después del hospital, Miguel está usando casi nada de insulina y su azúcar está perfecta. El vecino que tiene diabetes — el señor Fuentes — usa mucha más insulina que Miguel y tiene peor control. ¿Esto quiere decir que la diabetes de Miguel no era tan grave? ¿O que se está mejorando? Mi esposa y yo hablamos anoche y nos preguntamos si realmente necesita seguir con todas estas inyecciones.”
(Nurse, we want to understand what is happening. Three months after the hospital, Miguel is using almost no insulin and his glucose is perfect. The neighbor who has diabetes — Mr. Fuentes — uses much more insulin than Miguel and has worse control. Does this mean Miguel’s diabetes was not so serious? Or that it is getting better? My wife and I talked last night and wondered whether he really needs to keep with all these injections.)
Carmen: “El doctor en el hospital dijo que tenía diabetes tipo 1 para siempre. Pero si para siempre, ¿por qué necesita tan poca insulina ahora? Nos parece que algo cambió.”
(The doctor in the hospital said he had type 1 diabetes forever. But if forever, why does he need so little insulin now? It seems to us like something changed.)
Nurse Ana Cisneros-Morales nods. “Tienen toda la razón en que algo cambió — y lo que cambió es real. Lo que ustedes están viendo se llama la fase de luna de miel, o remisión parcial. Ocurre en la mayoría de los niños con diabetes tipo 1 en los primeros meses después del diagnóstico, y quiero explicarles exactamente qué es y por qué es importante que no cambiemos la insulina aunque parezca que Miguel casi no la necesita.”
(You are completely right that something changed — and what changed is real. What you are seeing is called the honeymoon phase, or partial remission. It occurs in most children with type 1 diabetes in the first months after diagnosis, and I want to explain to you exactly what it is and why it is important that we do not change the insulin even though it seems like Miguel barely needs it.)
Pedro: “¿Qué es exactamente esa fase?”
(What is that phase exactly?)
“Cuando Miguel llegó al hospital, su páncreas ya había perdido la mayor parte de sus células beta — las células que producen insulina. Ese proceso, que es un ataque del propio sistema inmune de Miguel contra esas células, había avanzado durante meses antes del hospital sin que ustedes lo supieran, porque el cuerpo puede compensar hasta que pierde el ochenta o noventa por ciento de su capacidad. En el hospital, con la insulina y los líquidos, estabilizamos a Miguel. Pero el diez o quince por ciento de las células beta que sobrevivieron ese ataque inicial — que estaban lesionadas pero no del todo destruidas — al recuperarse empezaron a producir insulina otra vez. Por eso Miguel necesita tan poca insulina ahora: esas células restantes están produciendo suficiente insulina propia para cubrir la mayor parte de sus necesidades. El resultado es el azúcar excelente que están viendo.”
(When Miguel arrived at the hospital, his pancreas had already lost most of its beta cells — the cells that produce insulin. That process, which is an attack by Miguel’s own immune system against those cells, had been advancing for months before the hospital without you knowing it, because the body can compensate until it loses eighty to ninety percent of its capacity. In the hospital, with insulin and fluids, we stabilized Miguel. But the ten or fifteen percent of beta cells that survived the initial attack — which were injured but not fully destroyed — as they recovered they began producing insulin again. That is why Miguel needs so little insulin now: those remaining cells are producing enough of their own insulin to cover most of his needs. The result is the excellent glucose you are seeing.)
Carmen: “Entonces la diabetes de Miguel se está mejorando — las células están volviendo.”
(So Miguel’s diabetes is improving — the cells are coming back.)
“Eso es exactamente lo que parece, y entiendo completamente por qué lo ve así. Pero necesito explicarles la parte más importante, y es que lo que parece que está pasando y lo que realmente está pasando son dos cosas diferentes. El ataque del sistema inmune que destruyó las otras células beta no ha parado. Continuó después del hospital, y continuó durante estos tres meses mientras Miguel estaba haciendo tan bien. Las células beta restantes están siendo destruidas poco a poco, a un ritmo más lento que al inicio, pero progresivamente. La luna de miel no es recuperación — es la supervivencia temporal de las últimas células beta mientras el sistema inmune termina de destruirlas.”
(That is exactly what it looks like, and I completely understand why you see it that way. But I need to explain the most important part, and it is that what seems to be happening and what is really happening are two different things. The immune attack that destroyed the other beta cells has not stopped. It continued after the hospital, and it continued during these three months while Miguel was doing so well. The remaining beta cells are being destroyed little by little, at a slower rate than at the beginning, but progressively. The honeymoon is not recovery — it is the temporary survival of the last beta cells while the immune system finishes destroying them.)
Pedro is quiet for a moment. “¿Y cuánto tiempo dura eso?”
(And how long does that last?)
“En la mayoría de los niños, la fase de luna de miel dura entre seis meses y dos años. En algunos, más tiempo. En algunos, menos. No podemos predecir exactamente cuándo va a terminar para Miguel. Lo que sí sabemos es que va a terminar — porque el sistema inmune va a completar la destrucción de las células beta restantes. La prueba de C-péptido que le hicimos hoy confirma que Miguel todavía produce un poco de insulina propia. Cuando esa producción baje a cero, Miguel va a necesitar significativamente más insulina externa — y ese cambio puede ocurrir en semanas, no en meses. Si en ese momento hemos parado o reducido mucho la insulina pensando que la luna de miel iba a durar, corremos el riesgo de que Miguel entre en cetoacidosis por la falta repentina de insulina.”
(In most children, the honeymoon phase lasts between six months and two years. In some, longer. In some, less. We cannot predict exactly when it will end for Miguel. What we do know is that it will end — because the immune system will complete the destruction of the remaining beta cells. The C-peptide test we did today confirms that Miguel still produces a little of his own insulin. When that production drops to zero, Miguel will need significantly more external insulin — and that change can happen over weeks, not months. If at that moment we have stopped or greatly reduced the insulin thinking the honeymoon would last, we risk Miguel going into ketoacidosis from the sudden lack of insulin.)
Carmen: “¿Y entonces para qué seguir con la insulina si de todas formas la luna de miel va a terminar?”
(And then what is the point of continuing with the insulin if the honeymoon is going to end anyway?)
“Hay dos razones. La primera es que si seguimos con la insulina durante la luna de miel, cuando las células beta restantes fallen, ya tenemos el sistema ajustado — sabemos qué dosis funcionan para Miguel, cómo responde su azúcar. Podemos ir subiendo la dosis gradualmente a medida que la producción propia baja, en lugar de tener que hacer ajustes de emergencia cuando las células fallen de golpe. La segunda razón es que los estudios muestran que mantener buen control del azúcar durante la luna de miel — exactamente lo que Miguel está haciendo — puede hacer que la luna de miel dure más tiempo. El azúcar alta estresa a las células beta sobrevivientes y puede acelerar su destrucción. La insulina que le ponemos a Miguel ahora no solo está protegiendo el azúcar de hoy — está protegiendo las células beta que todavía tiene.”
(There are two reasons. The first is that if we continue with the insulin during the honeymoon, when the remaining beta cells fail, we already have the system adjusted — we know what doses work for Miguel, how his glucose responds. We can gradually increase the dose as his own production drops, rather than having to make emergency adjustments when the cells fail suddenly. The second reason is that studies show that maintaining good glucose control during the honeymoon — exactly what Miguel is doing — may make the honeymoon last longer. High glucose stresses the surviving beta cells and can accelerate their destruction. The insulin we give Miguel now is not only protecting today’s glucose — it is protecting the beta cells he still has.)
Pedro nods slowly. “O sea que el azúcar perfecto de Miguel no es el final de la diabetes. Es la luna de miel.”
(So Miguel’s perfect glucose is not the end of the diabetes. It is the honeymoon.)
“Exactamente. Y la luna de miel es buena noticias — significa que Miguel todavía tiene algo de función propia, que su respuesta al tratamiento inicial fue excelente, que tiene excelente control ahora. Pero no es una señal de que la diabetes se va. Es una etapa del proceso. Nuestra meta es usarla bien: mantener ese buen control, proteger las células beta que quedan, y estar preparados para cuando termine.”
(Exactly. And the honeymoon is good news — it means Miguel still has some of his own function, that his response to initial treatment was excellent, that he has excellent control now. But it is not a signal that diabetes is leaving. It is a stage of the process. Our goal is to use it well: maintain that good control, protect the remaining beta cells, and be prepared for when it ends.)
Scenario 2: Sofía Herrera-Campos — San Antonio, Texas
Pediatric T1D nurse Isabel Morales-García and the parents who cannot understand why their daughter with no GI symptoms needs a celiac disease diagnosis
Sofía is seven years old. She lives in San Antonio with her parents, Eduardo Herrera-García, forty, a fourth-grade teacher, and Lucía Campos-Torres, thirty-eight, an office manager at a dental practice. She was diagnosed with type 1 diabetes twelve months ago after a routine school physical detected a random glucose of 287 mg/dL. She did not present in DKA. She was started on a continuous glucose monitor and an insulin pump, and in twelve months has achieved excellent glycemic control: A1c 6.8%, time-in-range 74%, median glucose 148 mg/dL. She has never been hospitalized since diagnosis. Eduardo and Lucía have become expert carb-counters and have adjusted their family meals to support Sofía’s management.
At today’s twelve-month follow-up, the endocrinologist reviews annual screening labs. Sofía’s tissue transglutaminase IgA (tTG-IgA) is 87 U/mL — the normal upper limit is 10 U/mL. Endomysial antibody IgA is positive. Total IgA is normal, ruling out the IgA deficiency that can cause false-negative celiac testing. The antibody results are consistent with active celiac disease. Sofía has never had diarrhea, abdominal cramping, bloating, or any gastrointestinal complaint. Her height is at the 50th percentile for age. Her weight is at the 48th percentile. She eats well, has good energy, and plays soccer with her neighborhood friends three days a week.
Eduardo’s face reflects a confusion that is almost distress. “¿Celiaquía? ¿Sofía nunca ha tenido nada del estómago. Ningún dolor, ninguna diarrea, ningún problema con la comida. ¿Cómo puede tener celiaquía si nunca ha tenido síntomas? ¿No es la celiaquía cuando el gluten te hace daño y tienes diarrea crónica?”
(Celiac disease? Sofía has never had anything with her stomach. No pain, no diarrhea, no problem with food. How can she have celiac disease if she has never had symptoms? Isn’t celiac disease when gluten harms you and you have chronic diarrhea?)
Lucía: “Y está creciendo normal. Estamos en el cincuenta por ciento de estatura. Si tuviera celiaquía sin tratamiento, ¿no debería estar más pequeña, más delgada? No tiene ningún signo de que algo esté mal.”
(And she is growing normally. We are at the fiftieth percentile for height. If she had untreated celiac disease, shouldn’t she be shorter, thinner? She has no sign that anything is wrong.)
Nurse Isabel Morales-García answers both questions together. “Tienen razón en que la celiaquía que la gente conoce — la celiaquía clásica con diarrea crónica, pérdida de peso, crecimiento deficiente — es la presentación más grave. Sofía no tiene esa presentación. Pero hay una forma de celiaquía que es igual de activa al nivel del intestino y completamente silenciosa al nivel de los síntomas. La diferencia no es que el intestino de Sofía esté bien — es que el intestino de Sofía está compensando. Y esa compensación tiene un límite que importa mucho en la diabetes.”
(You are right that the celiac disease people know — classic celiac with chronic diarrhea, weight loss, poor growth — is the most severe presentation. Sofía does not have that presentation. But there is a form of celiac that is equally active at the intestinal level and completely silent at the symptom level. The difference is not that Sofía’s intestine is fine — it is that Sofía’s intestine is compensating. And that compensation has a limit that matters a great deal in diabetes.)
Eduardo: “¿Cómo puede el intestino compensar algo que le está haciendo daño?”
(How can the intestine compensate for something that is harming it?)
“El intestino delgado tiene vellosidades — pequeñas proyecciones como dedos en la superficie interior que aumentan la superficie de absorción. En la celiaquía, las células del sistema inmune reaccionan al gluten del trigo atacando esas vellosidades y aplastándolas. Eso reduce la superficie de absorción. Pero el intestino delgado de los niños tiene una capacidad de adaptación: las vellosidades que no han sido aplastadas se pueden alargar y agrandar para compensar las que sí lo han sido. En Sofía, esa compensación está funcionando lo suficientemente bien como para mantener el crecimiento y evitar la diarrea clásica. Por eso se ve sana, por eso crece en el percentil cincuenta. Pero esa compensación es parcial e imperfecta. Y la imperfeccion tiene un efecto muy específico en la diabetes de Sofía.”
(The small intestine has villi — small finger-like projections on the inner surface that increase the absorption surface area. In celiac disease, immune cells react to gluten from wheat by attacking those villi and flattening them. That reduces the absorption surface area. But the small intestine of children has an adaptive capacity: the villi that have not been flattened can elongate and enlarge to compensate for the ones that have been. In Sofía, that compensation is working well enough to maintain growth and avoid the classic diarrhea. That is why she looks healthy, that is why she grows at the fiftieth percentile. But that compensation is partial and imperfect. And the imperfection has a very specific effect on Sofía’s diabetes.)
Lucía: “¿Qué efecto?”
(What effect?)
“La absorción del azúcar de la comida. El intestino delgado absorbe la glucosa de los carbohidratos que comemos a través de esas vellosidades. Cuando la atrofia de vellosidades es parcial e irregular — algunas zonas con vellosidades normales, otras con vellosidades aplastadas, otras en recuperación — la absorción de glucosa de una misma comida puede ser diferente de un día a otro, dependiendo de qué parte del intestino está activa en ese momento. Sofía puede comer exactamente los mismos cincuenta gramos de arroz un martes y un miércoles. El martes, absorbe cuarenta y cinco gramos de glucosa de ese arroz. El miércoles, absorbe treinta y dos gramos. Ustedes han calculado la insulina perfectamente para cincuenta gramos de carbohidratos — pero si lo absorbido es diferente cada día, el azúcar de Sofía va a ser impredecible aunque hagan todo perfectamente bien. ¿Recuerdan las noches que han tenido que tratar una hipoglucemia sin explicación? ¿O los picos de azúcar inexplicables de la misma comida? Esa variabilidad puede venir de la absorción irregular, no de errores de conteo.”
(The absorption of sugar from food. The small intestine absorbs glucose from the carbohydrates we eat through those villi. When the villous atrophy is partial and irregular — some areas with normal villi, others with flattened villi, others in recovery — the absorption of glucose from the same meal can be different from one day to the next, depending on which part of the intestine is active at that moment. Sofía can eat exactly the same fifty grams of rice on a Tuesday and a Wednesday. On Tuesday, she absorbs forty-five grams of glucose from that rice. On Wednesday, she absorbs thirty-two grams. You have calculated the insulin perfectly for fifty grams of carbohydrates — but if what is absorbed is different each day, Sofía’s glucose will be unpredictable even though you do everything perfectly well. Do you remember the nights you have had to treat an unexplained hypoglycemia? Or the unexplained glucose spikes from the same meal? That variability can come from irregular absorption, not from counting errors.)
Eduardo is nodding. “Llevamos semanas pensando que estábamos contando mal. Hay comidas que funcionan diferente cada vez que las hacemos. Pensábamos que era nosotros.”
(We have spent weeks thinking we were counting wrong. There are meals that work differently every time we make them. We thought it was us.)
“Puede que parte de esa variabilidad sea exactamente lo que les estoy describiendo. El intestino de Sofía está absorbiendo de manera irregular porque tiene vellosidades dañadas que el gluten sigue atacando cada vez que come pan, pasta, o cualquier alimento con trigo, cebada o centeno. Y ese daño está ocurriendo silenciosamente — sin dolor, sin diarrea, sin señal visible de que algo está pasando, excepto en los números de azúcar que ustedes no podían explicar.”
(It is possible that part of that variability is exactly what I am describing. Sofía’s intestine is absorbing irregularly because it has damaged villi that gluten continues to attack every time she eats bread, pasta, or any food with wheat, barley, or rye. And that damage is happening silently — without pain, without diarrhea, without visible sign that something is happening, except in the glucose numbers you could not explain.)
Lucía: “¿Y con la dieta sin gluten, eso mejora?”
(And with the gluten-free diet, does that improve?)
“Sí. Cuando el intestino de Sofía deja de recibir el gluten que lo estaba atacando, las vellosidades pueden recuperarse. Ese proceso toma seis a dieciocho meses. A medida que se recuperan, la absorción de glucosa se vuelve más predecible — y cuando la absorción es predecible, la insulina puede funcionar de la manera que calculamos. El control de la diabetes de Sofía puede mejorar significativamente simplemente porque la base sobre la que calculamos la insulina — cuánto glucosa va a absorber de la comida — se vuelve confiable. La buena noticia es que el tratamiento no es otro medicamento. Es una dieta. Una dieta sin gluten. Tiene su dificultad, especialmente para una niña de siete años, pero tenemos una nutricionista pediátrica que trabaja con familias con diabetes y celiaquía al mismo tiempo, y vamos a conectarlos con ella hoy.”
(Yes. When Sofía’s intestine stops receiving the gluten that was attacking it, the villi can recover. That process takes six to eighteen months. As they recover, glucose absorption becomes more predictable — and when absorption is predictable, insulin can work the way we calculate. Sofía’s diabetes control can improve significantly simply because the foundation on which we calculate insulin — how much glucose she is going to absorb from food — becomes reliable. The good news is that the treatment is not another medication. It is a diet. A gluten-free diet. It has its difficulty, especially for a seven-year-old girl, but we have a pediatric nutritionist who works with families managing diabetes and celiac disease at the same time, and we are going to connect you with her today.)
Eduardo: “¿Y por qué la diabetes tipo 1 y la celiaquía aparecen juntas? No entendemos por qué Sofía tiene las dos.”
(And why do type 1 diabetes and celiac disease appear together? We don’t understand why Sofía has both.)
“Porque las dos enfermedades comparten los mismos genes. No es mala suerte ni coincidencia — es la misma variante genética del sistema inmune que hace a Sofía vulnerable a las dos. Los genes en cuestión se llaman HLA — son genes que determinan cómo el sistema inmune reconoce lo que es propio y lo que es externo. Las variantes HLA que tiene Sofía — que son las que la predispusieron a la diabetes tipo 1 — son las mismas variantes que hacen que su sistema inmune reaccione al gluten del trigo atacando el intestino. Entre los niños con diabetes tipo 1, entre el cinco y el ocho por ciento desarrollan anticuerpos de celiaquía — comparado con el uno por ciento de la población general. No es que Sofía tuvo mala suerte dos veces. Es que tiene una predisposición del sistema inmune que se manifiesta en dos lugares. El páncreas y el intestino son los dos blancos de esa misma variante genética.”
(Because both diseases share the same genes. It is not bad luck or coincidence — it is the same genetic variant of the immune system that makes Sofía vulnerable to both. The genes in question are called HLA — they are genes that determine how the immune system recognizes what is self and what is foreign. The HLA variants Sofía has — the ones that predisposed her to type 1 diabetes — are the same variants that make her immune system react to wheat gluten by attacking the intestine. Among children with type 1 diabetes, between five and eight percent develop celiac antibodies — compared to one percent of the general population. It is not that Sofía had bad luck twice. It is that she has an immune system predisposition that manifests in two places. The pancreas and the intestine are the two targets of that same genetic variant.)
Lucía takes a long breath. “Y todas esas noches que no podíamos explicar los números. Sofía preguntaba por qué su azúcar subía con la pasta aunque contáramos bien. La respuesta era la celiaquía.”
(And all those nights we couldn’t explain the numbers. Sofía asked why her glucose rose with pasta even though we counted well. The answer was the celiac disease.)
“Es muy probable que sí. Y ahora que lo sabemos, podemos tratarlo y darle al control de la diabetes de Sofía la base estable que merece.”
(It is very likely yes. And now that we know, we can treat it and give Sofía’s diabetes management the stable foundation it deserves.)
Scenario 3: Carlos Vásquez-Mendoza — Dallas, Texas
Pediatric T1D nurse Claudia Herrera-Espinoza and the mother who cannot understand why insulin must be given during illness when her son has not eaten
Carlos is twelve years old. He lives in Dallas with his mother, Rosa Mendoza-Cruz, forty-two, a school secretary, and his grandmother, who lives with them and helps with childcare on weekdays. He was diagnosed with type 1 diabetes two years ago after presenting with a three-week history of polyuria, polydipsia, and weight loss. His A1c at diagnosis was 12.8%. He has been on a continuous glucose monitor and an insulin pump since six months after diagnosis. His most recent A1c is 7.2% with 64% time-in-range.
At today’s clinic visit, Rosa describes an incident from the previous week. Carlos contracted influenza — confirmed positive on a rapid antigen test at his pediatrician’s office. He was vomiting every two to three hours. He had not eaten any solid food since the morning before the vomiting began. Rosa called a neighbor, a woman whose husband has had type 2 diabetes for fifteen years. The neighbor said that if Carlos is not eating, the insulin is for food and he does not need it — that giving insulin without food is what causes low blood sugar. Rosa suspended the basal insulin delivery on the pump overnight. Carlos’s CGM showed glucose rising from 140 at 10 PM to 280 by 2 AM to 410 by 6 AM. Rosa woke up, gave a correction bolus, the glucose began to come down, and she took Carlos to urgent care at 9 AM with a glucose of 310 and trace urinary ketones. He was given IV fluids and an antiemetic, oral hydration was established, the pump was resumed, and he was discharged after four hours. He did not develop DKA. He recovered fully.
Rosa comes to today’s appointment frustrated and confused. She did not sleep for two nights. She does not understand why the neighbor’s advice — which seemed protective — produced a near-emergency.
“Enfermera, no entiendo. La señora Torres tiene razón cuando dice que la insulina es para la comida. Su esposo cuando no come no toma la insulina y está bien. Yo paraba la insulina para que Carlos no le bajara el azúcar porque no estaba comiendo. ¿Por qué eso fue mal? La insulina sin comida baja el azúcar, ¿no?”
(Nurse, I don’t understand. Mrs. Torres is right when she says that insulin is for food. Her husband when he doesn’t eat doesn’t take insulin and is fine. I was stopping the insulin so Carlos wouldn’t have low blood sugar because he wasn’t eating. Why was that wrong? Insulin without food lowers blood sugar, doesn’t it?)
Nurse Claudia Herrera-Espinoza sits beside Rosa. “Rosa, lo que hizo tiene toda la lógica del mundo. Ese razonamiento — insulina sin comida baja el azúcar — es correcto para la diabetes del esposo de la señora Torres. Pero la diabetes tipo 1 de Carlos es fundamentalmente diferente de la diabetes tipo 2. Y esa diferencia es exactamente lo que hace que la misma regla que protege al esposo de la señora Torres pudiera haber mandado a Carlos a la UCI. Quiero explicarle por qué.”
(Rosa, what you did makes complete sense. That reasoning — insulin without food lowers blood sugar — is correct for Mrs. Torres’s husband’s diabetes. But Carlos’s type 1 diabetes is fundamentally different from type 2 diabetes. And that difference is exactly what makes the same rule that protects Mrs. Torres’s husband potentially send Carlos to the ICU. I want to explain why.)
Rosa: “¿Cuál es la diferencia?”
(What is the difference?)
“En la diabetes tipo 2, el páncreas todavía produce insulina propia — generalmente bastante. El problema en la tipo 2 es que las células del cuerpo no responden bien a esa insulina propia. Cuando el esposo de la señora Torres no come, su páncreas produce muy poca insulina automáticamente — exactamente la cantidad que necesita para el estómago vacío. Tiene ese mecanismo de regulación automática. En la diabetes tipo 1, Carlos no tiene ese mecanismo. El ataque del sistema inmune que destruyó las células beta de Carlos destruyó completamente su capacidad de producir insulina propia. Cero. La única insulina que tiene Carlos en su cuerpo es la que programamos en la bomba. Si paramos la bomba, no hay insulina de ninguna fuente.”
(In type 2 diabetes, the pancreas still produces its own insulin — generally quite a bit. The problem in type 2 is that the body’s cells do not respond well to that own insulin. When Mrs. Torres’s husband does not eat, his pancreas automatically produces very little insulin — exactly the amount he needs for an empty stomach. He has that automatic regulation mechanism. In type 1 diabetes, Carlos does not have that mechanism. The immune attack that destroyed Carlos’s beta cells completely destroyed his capacity to produce his own insulin. Zero. The only insulin Carlos has in his body is what we program in the pump. If we stop the pump, there is no insulin from any source.)
Rosa: “Pero sin comida, ¿para qué necesita insulina?”
(But without food, what does he need insulin for?)
“Esa es exactamente la pregunta que necesito responder, porque la respuesta explica todo lo que le pasó a Carlos esa noche. El cuerpo produce glucosa por sí solo — sin ninguna comida — todo el tiempo. El hígado produce glucosa constantemente a partir de aminoácidos y de las reservas de glucosa que guarda. Esa glucosa que produce el hígado es lo que mantiene el cerebro funcionando entre comidas, durante el sueño, en el ayuno. En una persona sin diabetes, la insulina producida por el páncreas constantemente regula esa producción hepática — le dice al hígado cuánta glucosa producir. La insulina basal en la bomba de Carlos cumple exactamente esa función. Si paramos la insulina basal, no hay nada que controle la producción de glucosa del hígado de Carlos, y esa producción sube.”
(That is exactly the question I need to answer, because the answer explains everything that happened to Carlos that night. The body produces glucose by itself — without any food — all the time. The liver produces glucose constantly from amino acids and from the glucose reserves it stores. That glucose the liver produces is what keeps the brain functioning between meals, during sleep, during fasting. In a person without diabetes, the insulin produced by the pancreas constantly regulates that hepatic production — it tells the liver how much glucose to produce. The basal insulin in Carlos’s pump fulfills exactly that function. If we stop the basal insulin, there is nothing to control the glucose production from Carlos’s liver, and that production rises.)
Rosa: “¿Pero eso también pasa cuando uno está sano y en ayunas?”
(But does that also happen when someone is healthy and fasting?)
“Sí — y en una persona sin diabetes, el páncreas produce la insulina necesaria para mantener esa producción hepática controlada durante el ayuno. En Carlos, la bomba cumple esa función. Pero hay un segundo factor durante la enfermedad que hace la situación mucho más seria. Cuando el cuerpo está enfermo — con fiebre, náuseas, dolor, infección — activa un sistema de emergencia que existe desde hace millones de años: las hormonas del estrés. El cuerpo libera glucagón, que viene del páncreas — de las células que producen glucagón, que en la diabetes tipo 1 no son destruidas, solo las células que producen insulina lo son. Libera cortisol de las glándulas suprarrenales. Libera adrenalina. Todas esas hormonas le mandan al hígado una señal de emergencia: produce más glucosa ahora, el cuerpo está bajo estrés. El hígado obedece — saca glucosa de sus reservas y la produce de aminoácidos. Esa glucosa extra entra a la sangre. En una persona sin diabetes, el páncreas produce más insulina para compensar. En Carlos, no hay páncreas que compense. Con la bomba parada, las hormonas del estrés mandaban glucosa a la sangre y no había nada para bloquear ese proceso. Por eso el azúcar subió de 140 a 280 a 410 sin que Carlos hubiera comido nada.”
(Yes — and in a person without diabetes, the pancreas produces the insulin needed to keep that hepatic production controlled during fasting. In Carlos, the pump fulfills that function. But there is a second factor during illness that makes the situation much more serious. When the body is ill — with fever, nausea, pain, infection — it activates an emergency system that has existed for millions of years: stress hormones. The body releases glucagon, which comes from the pancreas — from the cells that produce glucagon, which in type 1 diabetes are not destroyed, only the cells that produce insulin are. It releases cortisol from the adrenal glands. It releases epinephrine. All those hormones send the liver an emergency signal: produce more glucose now, the body is under stress. The liver obeys — it draws glucose from its reserves and produces it from amino acids. That extra glucose enters the blood. In a person without diabetes, the pancreas produces more insulin to compensate. In Carlos, there is no pancreas to compensate. With the pump stopped, the stress hormones were sending glucose to the blood and there was nothing to block that process. That is why the glucose rose from 140 to 280 to 410 without Carlos having eaten anything.)
Rosa: “¿Y los ácidos que mencionó el médico del urgencias? ¿Las cetonas?”
(And the acids the urgent care doctor mentioned? The ketones?)
“Eso es el tercer efecto de no tener insulina durante la enfermedad. Sin insulina, el azúcar no puede entrar bien a las células del músculo y de la grasa — esas células necesitan insulina para abrir sus puertas al azúcar. El cerebro detecta que las células no tienen azúcar aunque el azúcar en la sangre esté alta — porque el azúcar en la sangre alta sin insulina no llega bien adentro de las células. El cuerpo interpreta esto como hambre. Para alimentar las células, empieza a romper la grasa. La grasa se convierte en ácidos grasos, y esos ácidos grasos en el hígado se convierten en cuerpos cetónicos — las cetonas. Las cetonas se acumulan en la sangre y acidifican la sangre. Eso es la cetoacidosis diabética. No viene de comer — viene de no tener insulina mientras las hormonas del estrés activan todos esos procesos al mismo tiempo. En Carlos, la noche que paró la bomba, los tres procesos estaban ocurriendo a la vez: el hígado produciendo glucosa sin control, las células sin azúcar aunque la sangre estuviera alta, y la grasa rompiéndose en ácidos. Llegaron a urgencias antes de que eso se convirtiera en cetoacidosis completa. Llegaron a tiempo. Pero fue el tiempo de llegar — no sobró mucho.”
(That is the third effect of not having insulin during illness. Without insulin, glucose cannot enter the muscle and fat cells well — those cells need insulin to open their doors to glucose. The brain detects that cells do not have glucose even though blood glucose is high — because high blood glucose without insulin does not reach well inside the cells. The body interprets this as starvation. To feed the cells, it begins to break down fat. Fat converts to fatty acids, and those fatty acids in the liver convert to ketone bodies — the ketones. Ketones accumulate in the blood and acidify the blood. That is diabetic ketoacidosis. It does not come from eating — it comes from having no insulin while stress hormones activate all those processes at the same time. In Carlos, the night you stopped the pump, the three processes were occurring simultaneously: the liver producing glucose uncontrolled, cells without glucose even though blood was high, and fat breaking down into acids. They arrived at urgent care before that became full ketoacidosis. You arrived in time. But it was the time to arrive — not much was left.)
Rosa is silent for a moment. “La señora Torres no sabía que la diabetes de Carlos es diferente.”
(Mrs. Torres did not know that Carlos’s diabetes is different.)
“No. Y usted tampoco tenía razón para saberlo — es una diferencia que no es obvia y que no explicamos bien en las instrucciones que se dan en el hospital. Por eso lo estamos explicando hoy, y lo vamos a escribir para que lo tenga. La regla de la diabetes tipo 1 durante una enfermedad es una sola y hay que recordarla siempre: la insulina basal nunca para durante una enfermedad. La comida puede parar — si Carlos vomita, no comemos. El líquido puede ser solo agua o Pedialyte si no tolera más. Pero la insulina basal sigue. Nunca para. Además, durante la enfermedad: verificamos el azúcar de Carlos cada dos horas, no cada seis. Verificamos las cetonas en la orina o en la sangre cuando el azúcar pasa de doscientos cincuenta. Damos correcciones de insulina aunque Carlos no haya comido — porque la enfermedad está subiendo el azúcar sola, no la comida. Y si Carlos vomita tantas veces que no puede tomar ni sorbos pequeños de líquido, llaman a la línea del equipo de diabetes inmediatamente — eso es una emergencia, aunque el azúcar todavía no esté muy alta.”
(No. And you had no reason to know it — it is a difference that is not obvious and that we do not explain well in the instructions given at the hospital. That is why we are explaining it today, and we are going to write it down so you have it. The rule in type 1 diabetes during illness is one and must always be remembered: basal insulin never stops during illness. Food can stop — if Carlos vomits, we do not eat. Fluid can be just water or Pedialyte if he cannot tolerate more. But basal insulin continues. It never stops. In addition, during illness: we check Carlos’s glucose every two hours, not every six. We check ketones in urine or blood when glucose passes two hundred fifty. We give insulin corrections even though Carlos has not eaten — because the illness is raising the glucose on its own, not the food. And if Carlos vomits so many times that he cannot take even small sips of fluid, call the diabetes team line immediately — that is an emergency, even if glucose is not yet very high.)
Rosa takes out her phone. “Lo estoy escribiendo ahora mismo. La insulina basal nunca para durante una enfermedad.”
(I am writing it down right now. Basal insulin never stops during illness.)
“Exactamente. Y hay una segunda parte igual de importante: la diabetes tipo 1 de Carlos no funciona como la diabetes tipo 2 del esposo de la señora Torres. Las reglas son diferentes porque el problema es diferente. En la tipo 2, el páncreas produce insulina. En la tipo 1, no. Cuando tenga dudas sobre qué hacer durante una enfermedad — sobre cualquier regla que le diga alguien sobre la diabetes — llame a nuestra línea. Está para eso, veinticuatro horas al día. Y lo que pasó la semana pasada — llegar al urgencias con el azúcar alta y las cetonas en traza — fue un final aceptable de una noche muy difícil. Llegará mejor preparada la próxima vez.”
(Exactly. And there is a second part equally important: Carlos’s type 1 diabetes does not work like Mrs. Torres’s husband’s type 2 diabetes. The rules are different because the problem is different. In type 2, the pancreas produces insulin. In type 1, it does not. When you have doubts about what to do during an illness — about any rule someone tells you about diabetes — call our line. It is there for that, twenty-four hours a day. And what happened last week — arriving at urgent care with high glucose and trace ketones — was an acceptable ending to a very difficult night. You will arrive better prepared next time.)
Frequently asked questions
How do pediatric T1D clinic nurses explain to Spanish-speaking parents why insulin must continue during the honeymoon phase when glucose is near-normal on minimal doses?
The explanation requires distinguishing between the child’s apparent glycemic stability during the honeymoon phase and the ongoing biological reality of continued autoimmune beta-cell destruction. The honeymoon phase — partial clinical remission — occurs because the initial autoimmune assault destroys most but not all pancreatic beta cells; the surviving 10 to 15% of beta-cell mass still produce measurable C-peptide and enough endogenous insulin to reduce exogenous requirements to as low as 0.1 to 0.3 units per kilogram per day with near-normal glucose levels. The critical mechanistic fact is that the same autoimmune attack — CD4+ T helper cells, CD8+ cytotoxic T cells, and macrophages infiltrating the islets and destroying beta cells through perforin-mediated cytolysis and inflammatory cytokines — continues during the honeymoon at a reduced but ongoing pace. The immune attack did not stop when the child left the hospital; it has slowed because most of its target cells are gone. The remaining beta cells will be progressively destroyed over months to years; the transition from partial to complete insulin deficiency can be rapid and unpredictable; and if the family reduces or stops exogenous insulin based on the low requirements during the honeymoon, the child may have insufficient exogenous insulin precisely when endogenous production disappears, creating DKA risk. Additionally, maintaining good glucose control during the honeymoon reduces glucotoxicity and oxidative stress on surviving beta cells, potentially prolonging the phase. The insulin given during the honeymoon also ensures the family and team have a calibrated dosing system ready for the transition. Key Spanish frame: la fase de luna de miel no significa que la diabetes se está mejorando; el ataque del sistema inmune no ha parado; esas células beta restantes van a ser destruidas; cuando la función restante falle, Miguel va a necesitar más insulina de golpe.
How do pediatric T1D clinic nurses explain to Spanish-speaking parents why their child with T1D needs annual celiac antibody screening when the child has no gastrointestinal symptoms?
The explanation requires two components: the genetic mechanism linking T1D and celiac co-occurrence, and the glycemic consequence of silent celiac in T1D. Type 1 diabetes and celiac disease share HLA class II haplotypes — specifically HLA-DR3/DQ2 (DQA1*05:01/DQB1*02:01) and HLA-DR4/DQ8 (DQA1*03:01/DQB1*03:02). These variants present self-antigens to CD4+ T cells in the pancreatic lymph nodes (islet autoantigens, driving T1D) and gluten-derived gliadin peptides in intestinal lamina propria (driving celiac). A child with these haplotypes has the genetic substrate for both autoimmune attacks. The 5 to 8% celiac co-occurrence rate in T1D children (versus 1% in the general population) reflects this shared genetic predisposition. Pediatric celiac is frequently asymptomatic because partial villous atrophy can be compensated by adaptive hypertrophy of surviving villi, preventing the classic presentation of chronic diarrhea and failure to thrive. Despite the absence of symptoms, partial villous atrophy produces variable, unpredictable carbohydrate absorption — the intestinal surface area for SGLT1-mediated glucose uptake varies day to day depending on villous function in different intestinal segments. In T1D, where insulin dosing is calculated based on fixed carbohydrate grams, this variability produces unexplained glucose swings that appear as counting errors or insulin sensitivity fluctuations but are actually absorption variability. The gluten-free diet allows villous recovery over 6 to 18 months, restoring predictable carbohydrate absorption and stabilizing glycemic management. Key Spanish frame: la diabetes tipo 1 y la celiaquía comparten los mismos genes del sistema inmune; con celiaquía silenciosa, la absorción del azúcar de la comida se vuelve impredecible, y cuando la absorción es impredecible, la insulina no puede funcionar bien aunque hagamos todo bien.
How do pediatric T1D clinic nurses explain to Spanish-speaking parents why insulin must be given during illness even when the child is vomiting and not eating?
The explanation requires dismantling the “insulin is for food” model that is accurate for type 2 diabetes but dangerous in type 1, and replacing it with the stress-hormone physiology of sick-day DKA. In type 1 diabetes, there is no endogenous insulin — zero. The autoimmune destruction of beta cells has eliminated the pancreas’s insulin-secreting capacity entirely. In type 2 diabetes, not eating reduces the need for exogenous insulin supplements because the pancreas reduces endogenous insulin secretion automatically to match the lower carbohydrate load. In T1D, no automatic regulation exists. Basal insulin serves to suppress continuous hepatic glucose output — gluconeogenesis from amino acids and glycerol, and glycogenolysis from stored glycogen — that occurs at all times, independent of eating. When basal insulin is stopped, hepatic glucose output rises. During illness, this baseline hepatic output is massively amplified by counter-regulatory hormone release — glucagon (from pancreatic alpha cells, which are NOT destroyed in T1D), cortisol, epinephrine, and growth hormone — which drive hepatic glucose production upward as an emergency response to physiological stress. In a functioning pancreas, this counter-regulatory surge triggers compensatory insulin secretion. In T1D, no compensation exists. Simultaneously, without insulin to activate GLUT4 in muscle and adipose cells, cellular glucose uptake is impaired; the brain interprets starvation; adipose hormone-sensitive lipase drives lipolysis releasing free fatty acids; hepatic beta-oxidation of FFAs produces acetyl-CoA that exceeds TCA capacity, driving ketogenesis; ketone accumulation causes metabolic acidosis. DKA in T1D during illness arises from stress-hormone physiology, independent of carbohydrate intake. Key Spanish frame and sick day rule: la insulina basal nunca para durante una enfermedad en la diabetes tipo 1; la comida puede parar — la insulina basal no para nunca.
What are the key clinical Spanish phrases for explaining the honeymoon phase, celiac co-screening, and sick day rules to Spanish-speaking families in the pediatric T1D clinic?
For the honeymoon phase: “La fase de luna de miel no significa que la diabetes está mejorando — significa que todavía quedan unas pocas células beta que producen un poco de insulina propia.” (The honeymoon phase does not mean diabetes is improving — it means there are still a few beta cells producing a little of their own insulin.) “El ataque del sistema inmune no ha parado — esas células beta restantes están siendo destruidas poco a poco.” (The immune attack has not stopped — those remaining beta cells are being destroyed little by little.) “Cuando las células restantes fallen, Miguel va a necesitar mucho más insulina de repente — si hemos parado la insulina pensando que ya no era necesaria, ese momento puede producir una crisis diabética.” (When the remaining cells fail, Miguel will need much more insulin suddenly — if we have stopped insulin thinking it was no longer needed, that moment can produce a diabetic crisis.) For celiac co-screening: “La diabetes tipo 1 y la celiaquía comparten los mismos genes del sistema inmune — no es mala suerte ni coincidencia.” (Type 1 diabetes and celiac disease share the same immune system genes — it is not bad luck or coincidence.) “La celiaquía silenciosa no produce diarrea porque el intestino compensa, pero el daño sigue ocurriendo y hace que la absorción del azúcar de la comida sea impredecible.” (Silent celiac does not produce diarrhea because the intestine compensates, but the damage continues occurring and makes glucose absorption from food unpredictable.) “Cuando la absorción es impredecible, la insulina no puede funcionar bien aunque hagamos todo bien — y con la dieta sin gluten, la absorción se vuelve predecible otra vez.” (When absorption is unpredictable, insulin cannot work well even when we do everything right — and with the gluten-free diet, absorption becomes predictable again.) For sick day rules: “En la diabetes tipo 1, no hay insulina propia — zero. La única insulina que tiene Carlos es la que programamos en la bomba.” (In type 1 diabetes, there is no own insulin — zero. The only insulin Carlos has is what we program in the pump.) “Cuando Carlos está enfermo, aunque no coma nada, las hormonas del estrés de la enfermedad le mandan al hígado que produzca glucosa de emergencia — y sin insulina para detener ese proceso, la glucosa sube.” (When Carlos is ill, even if he eats nothing, the stress hormones from illness tell the liver to produce emergency glucose — and without insulin to stop that process, glucose rises.) “La regla de la diabetes tipo 1 durante una enfermedad es una sola: la insulina basal nunca para. La comida puede parar — la insulina basal no para nunca.” (The rule in type 1 diabetes during illness is one: basal insulin never stops. Food can stop — basal insulin never stops.)
What are the most important communication challenges specific to Spanish-speaking families in the pediatric type 1 diabetes outpatient clinic that standard handouts do not address?
Three structural communication challenges arise specifically in the pediatric T1D outpatient clinic and are inadequately addressed by translated handouts. The first is the honeymoon phase mismatch between observation and prognosis. Families observe a child whose glucose runs between 80 and 140, whose A1c is 5.9%, whose insulin requirement has dropped from 0.8 to 0.2 units per kilogram per day — and they reasonably conclude that the situation is improving. Everything they can observe confirms this conclusion. The difficulty is that the improvement is real at the level of glycemic control (observable) but misleading as a signal about disease trajectory (unobservable). The autoimmune destruction of beta cells is a cellular process invisible to the family, and the honeymoon’s apparent stability conceals the ongoing loss of residual beta-cell mass. A nurse who can make this distinction visible — explaining that the low insulin requirement reflects surviving beta cells whose destruction is ongoing rather than halted, and that the transition to complete insulin deficiency will require upward dose adjustment that must precede the loss rather than follow it — gives the family a reason to maintain insulin adherence that their observation of apparent improvement cannot provide. A common cultural frame that creates additional friction is the family member or neighbor who interprets the low dose and good glucose as confirmation that the initial diagnosis was incorrect or that the diabetes has resolved. The nurse who can name this possibility directly — acknowledging that the glucose looks exactly like what a resolved diabetes would look like, and then explaining the biological reason it is not — addresses the credibility challenge that silence leaves open. The second challenge is the celiac co-screening message, which fails for two reasons. First, families do not expect a second autoimmune diagnosis from a diabetes appointment; the shared HLA haplotype explanation resolves this category error by making clear these are not two unrelated diseases screened for opportunistically, but two manifestations of the same genetic immune susceptibility. Second, the motivation for treating asymptomatic celiac in T1D is glycemic — absent from standard celiac handouts written for the general population. A family that understands the celiac-glycemic link (villous atrophy produces variable carbohydrate absorption; variable absorption makes insulin dosing unreliable; the glycemic variability attributed to counting errors may be absorption variability) has a diabetes-relevant reason to pursue a gluten-free diet that symptom-focused celiac materials cannot provide. The third challenge is the sick day rules message, which fails because the intuitive model it must overcome is not wrong in general — it is specifically wrong for T1D, and the family has no reason to know that their model (insulin is for food) is the T2D model rather than the T1D model. The distinction between T1D and T2D physiology is not consistently communicated at diagnosis, particularly in families with T2D relatives who serve as informal advisors. A nurse who can name this model directly — validating that the neighbor’s advice is correct for T2D and explaining precisely why T1D is different (zero endogenous insulin means zero capacity to suppress counter-regulatory hepatic glucose production regardless of carbohydrate intake) — converts a neighbor’s reasonable advice into an actively dangerous rule while preserving the family’s trust in both the neighbor’s good faith and the nurse’s expertise.
Pediatric type 1 diabetes clinic nursing requires building three biological frameworks in families who arrive with three reasonable but incomplete models: that near-normal glucose on minimal insulin signals disease resolution, that no GI symptoms means no intestinal problem, and that insulin is for food. Each of these models is sensible within the domain of observation the family has access to. Each leads to clinical decisions that produce avoidable complications. The nurse who can explain why the honeymoon phase’s apparent stability conceals ongoing autoimmune destruction that will inevitably complete, why asymptomatic celiac produces the glucose variability that appears as counting errors, and why stress-hormone physiology makes basal insulin non-negotiable during illness regardless of carbohydrate intake, is closing three gaps that no translated handout and no English-only consultation can close in the same way.
In all three conversations, the families were engaged, attentive, and doing everything they had been told. The honeymoon phase appeared to them as recovery because their glycemic management was working. The celiac disease appeared absent because the GI symptoms were absent. The sick day insulin appeared unnecessary because the insulin-for-food model — borrowed from the T2D context they knew — seemed protective. The bilingual nurse who can give each family the biological layer their direct observation misses — in the idiom and directness of the Spanish they think in, in the time available in a pediatric endocrinology clinic — is doing what no discharge summary and no educational pamphlet can do in their place.
For related reading on communication challenges in pediatric specialty clinics where management requires families to act on biological processes they cannot observe, see Spanish for pediatric endocrinology clinic nurses (Hashimoto’s thyroiditis levothyroxine dosing, growth hormone deficiency monitoring, and adrenal insufficiency sick day rules) and Spanish for type 1 diabetes clinic nurses (adult T1D: LADA diagnosis requiring insulin replacement, A1c versus time-in-range, and hypoglycemia unawareness). For the HLA-linked autoimmune comorbidities in pediatric chronic disease, see Spanish for pediatric metabolic disease clinic nurses and Spanish for pediatric nephrology clinic nurses. The 50 Spanish ED phrases PDF covers the acute hyperglycemia and DKA triage conversations that precede and sometimes follow these outpatient management discussions. Our full free practice library is available without login. For more long-form clinical-Spanish posts, visit the ClinicaLingo blog.